🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06512974
Recruiting Not applicable

NeuroTrainer Cognitive Training For Academic Focus

NCT06512974 · tracked via the Priya Life Science USA tracker
Sponsor
NeuroTrainer
Phase
Not applicable
Started
2024-09-01
Last updated
2025-06-19

Condition(s) studied

ADHD - Combined TypeADHD Predominantly Inattentive TypeADHD, Predominantly Hyperactive - Impulsive

Investigational drug(s) / intervention(s)

NeuroTrainer

NeuroTrainer: Virtual reality based cognitive training

Study summary

This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.

Eligibility

Sex
ALL
Min age
11 Years
Max age
17 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Diagnostic criteria met ADHD for any ADHD presentation type, with severity ratings of subthreshold, moderate or severe * Estimated IQ of 80 or greater * Between 11-17 years of age Exclusion Criteria: * Presence of suicidality * Presence of psychotic disorders * Visual or hearing impairment * Presence of severe depression

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Marquette Senior High School Marquette Michigan Recruiting
Westside High School Omaha Nebraska Recruiting
One City Schools Madison Wisconsin Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06512974 on ClinicalTrials.gov ↗ ← All trials in the USA